Free Trial

Eagle Pharmaceuticals (EGRX) Competitors

Eagle Pharmaceuticals logo
$3.00 +0.11 (+3.63%)
As of 07/3/2025 09:30 AM Eastern

EGRX vs. BIOA, CGEN, ALEC, GALT, ACOG, IKT, ALTS, KYTX, RAPT, and LXEO

Should you be buying Eagle Pharmaceuticals stock or one of its competitors? The main competitors of Eagle Pharmaceuticals include BioAge Labs (BIOA), Compugen (CGEN), Alector (ALEC), Galectin Therapeutics (GALT), Alpha Cognition (ACOG), Inhibikase Therapeutics (IKT), ALT5 Sigma (ALTS), Kyverna Therapeutics (KYTX), Rapt Therapeutics (RAPT), and Lexeo Therapeutics (LXEO). These companies are all part of the "pharmaceutical products" industry.

Eagle Pharmaceuticals vs. Its Competitors

BioAge Labs (NASDAQ:BIOA) and Eagle Pharmaceuticals (NASDAQ:EGRX) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

85.4% of Eagle Pharmaceuticals shares are held by institutional investors. 20.8% of BioAge Labs shares are held by insiders. Comparatively, 28.9% of Eagle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, BioAge Labs had 2 more articles in the media than Eagle Pharmaceuticals. MarketBeat recorded 2 mentions for BioAge Labs and 0 mentions for Eagle Pharmaceuticals. Eagle Pharmaceuticals' average media sentiment score of 0.00 beat BioAge Labs' score of -0.17 indicating that Eagle Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
BioAge Labs Neutral
Eagle Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
BioAge LabsN/A N/A N/A
Eagle Pharmaceuticals N/A N/A N/A

Eagle Pharmaceuticals has higher revenue and earnings than BioAge Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioAge LabsN/AN/A-$71.11MN/AN/A
Eagle Pharmaceuticals$257.55M0.15$35.64MN/AN/A

Summary

Eagle Pharmaceuticals beats BioAge Labs on 5 of the 6 factors compared between the two stocks.

Get Eagle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EGRX vs. The Competition

MetricEagle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$38.96M$784.80M$5.53B$9.03B
Dividend YieldN/A4.84%5.24%4.01%
P/E RatioN/A1.0919.3119.89
Price / Sales0.15230.50424.59117.07
Price / Cash0.4023.4426.2128.59
Price / BookN/A6.237.925.55
Net Income$35.64M-$27.94M$3.17B$248.49M
7 Day Performance3.45%2.21%2.18%5.37%
1 Month Performance33.33%8.98%1.25%6.63%
1 Year Performance-45.45%11.57%33.90%21.20%

Eagle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EGRX
Eagle Pharmaceuticals
N/A$3.00
+3.6%
N/A-45.5%$38.96M$257.55M0.00100Gap Down
BIOA
BioAge Labs
N/A$4.13
-1.7%
N/AN/A$150.57MN/A0.00N/A
CGEN
Compugen
1.5238 of 5 stars
$1.78
+7.2%
$4.00
+124.7%
+14.1%$148.13M$27.86M-11.1370Positive News
ALEC
Alector
3.7977 of 5 stars
$1.40
-5.4%
$4.00
+185.7%
-66.4%$147.99M$100.56M-1.11270
GALT
Galectin Therapeutics
1.6317 of 5 stars
$2.11
-9.4%
$6.00
+184.4%
+4.6%$147.47MN/A-2.939Gap Up
ACOG
Alpha Cognition
1.6643 of 5 stars
$9.33
+2.5%
$20.00
+114.4%
N/A$145.86MN/A-7.77N/AGap Up
IKT
Inhibikase Therapeutics
1.3436 of 5 stars
$1.95
+20.4%
$6.50
+233.3%
+62.9%$144.97M$260K-0.736
ALTS
ALT5 Sigma
0.0587 of 5 stars
$7.24
-10.9%
N/AN/A$141.91M$12.53M0.00170
KYTX
Kyverna Therapeutics
1.2685 of 5 stars
$3.07
-6.4%
$18.50
+502.6%
-58.7%$141.76M$7.03M-0.9196
RAPT
Rapt Therapeutics
4.1986 of 5 stars
$8.00
-5.1%
$24.00
+200.0%
-63.7%$139.40M$1.53M-0.4280
LXEO
Lexeo Therapeutics
1.8733 of 5 stars
$4.02
-2.4%
$16.60
+312.9%
-71.4%$136.77M$650K-1.2258News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:EGRX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners